Europe Outsourcing Outlook 2015
For a complimentary listing in the Europe Outsourcing Outlook 2015, please download and complete the form below. The Outsourcing Outlook is published in March as a supplement to Pharmaceutical Technology Europe's regular issue.
For a complimentary listing in the Europe Outsourcing Outlook 2015, please download and complete the form below.
The Outsourcing Outlook is published in March as a supplement to Pharmaceutical Technology Europe's regular issue.
Submission Deadline
February 26, 2015
Form Submission Instructions
Send completed forms to ptprojects@advanstar.com with Subject Line “European Outsourcing Outlook 2015 Form.”
Contact us with any Questions
Chris Lawson
Associate Publisher
Tel: +44(0)124 462 9324
clawson@advanstar.com
Submitted information will be held in confidence until publication. Final decisions regarding what details are included for publication is based on editorial judgment, reader interest, and available space.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
